Altimmune, Inc. (ALT)
NASDAQ · Healthcare
Altimmune, Inc. Long Term Debt 2010–2025
Altimmune, Inc. annual long term debt history from 2016 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Altimmune, Inc. long term debt as of December 31, 2025: 34.3M, a 648.46% increase year-over-year.
- Altimmune, Inc. long term debt for 2025 were 34.3M, a 648.46% increase from 2022.
- Altimmune, Inc. long term debt for 2022 were 4.6M, a 215.06% increase from 2021.
- Altimmune, Inc. long term debt for 2021 were 1.5M, a 20.48% decrease from 2020.
- Altimmune, Inc. long term debt for 2020 were 1.8M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Altimmune, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $34 |
| 2022 | $5 |
| 2021 | $1 |
| 2020 | $2 |
| 2019 | $2 |
| 2018 | $1 |
| 2017 | $1 |
| 2016 | $1 |
Altimmune, Inc. Long Term Debt — FAQ
Altimmune, Inc. (ALT) long term debt over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALT's long term debt history?
The chart and table above show Altimmune, Inc.'s long term debt by year and by quarter, including the growth rate.